Blueteq Ltd

Histologically confirmed stage III (unresectable) or stage IV melanoma PS 0 or 1 No previous treatment with any of anti-Programmed Death receptor-1 (PD-1), anti-Programmed Death-1 ligand-1 (PD-L1), anti-PD-L2, or anti-cytotoxic T lymphocyte associated antigen-4 (anti-CTLA-4) antibody. ................
................